The new data comes from the phase 2/3 SKYSCRAPER-06 study, which evaluated tiragolumab in combination with Roche’s PD-L1 inhibitor Tecentriq (atezolizumab) and chemotherapy as a first-line ...

This advertisement has not loaded yet, but your article continues below. Police exchanged gunfire with the man, which left him and an officer wounded Samples are on their way to Winnipeg's ...